| Bioactivity | Seladelpar lysine is an orally active, potent (50% effect concentration EC50 2 nM), and specific PPAR-δ agonist[1][2]. |
| CAS | 928821-41-4 |
| Formula | C27H37F3N2O7S |
| Molar Mass | 590.65 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bays HE, et al. MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin. J Clin Endocrinol Metab. 2011 Sep;96(9):2889-97. [2]. Haczeyni F, et al. The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. Hepatol Commun. 2017 Jul 31;1(7):663-674. |
Seladelpar (lysine)
CAS: 928821-41-4 F: C27H37F3N2O7S W: 590.65
Seladelpar lysine is an orally active, potent (50% effect concentration EC50 2 nM), and specific PPAR-δ agonist.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.